The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up.
Rapat PittayanonR RerknimitrN KlaikaewA SanpavatS ChaithongratV MahachaiP KullavanijayaAlan N BarkunPublished in: Alimentary pharmacology & therapeutics (2017)
Male patients and those with incomplete GIM are at greatest risk of developing dysplasia or early gastric cancer. Further studies in determining optimal surveillance intervals and impact on cancer incidence and mortality are still required.